GSK buys US cancer drug maker Nuvalent for $10.6bn – The Times

2 months ago

2 Views

1 Min Read

GSK buys US cancer drug maker Nuvalent for $10.6bn The Times
GSK to buy US cancer biotech Nuvalent for $10.6bn Financial Times
GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm The Guardian
GSK enters agreement to acquire Nuvalent, Inc. GSK
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push WSJ